Lenalidomide as a Highly-Effective Maintenance Therapy in Myeloma

December 13, 2016
Graham Jackson, MD, PhD

Graham Jackson, MD, PhD, Northern Institute for Cancer Research, Newcastle University, discusses results of a study that determined lenalidomide (Revlimid) is a highly-effective maintenance therapy in myeloma patients of all ages.